Embargoed until 10:30 a.m. PT/ 1:30 p.m. ET, Tuesday, Nov. 14, 2017
This news tip contains updated study information not reflected in the abstract.
ANAHEIM, California, Nov. 14, 2017 — Smoking among the working population is predicted to cost Australia an estimated $340 billion in lost productivity, according to preliminary research presented at the American Heart Association’s Scientific Sessions 2017, a premier global exchange of the latest advances in cardiovascular science for researchers and clinicians.
The health costs of smoking are well-known, but the impact on productivity is not. Currently, 1.9 million Australians (13.9 percent) between 20 and 69 years of age are smokers.
Researchers used published data on the rate of deaths, absenteeism, and working while sick among smokers to estimate how much productivity would be lost to smoking in the working-age population until age 69. They found that:
- Australia’s currently smoking workforce would lose an estimated 2.9 million years of life and 2.7 million years of productive years lost, equating to an estimated $340 billion in U.S. dollars – not including healthcare expenditures.
- This represents a 6 percent loss in productive years and a 4 percent loss in years of life compared to a non-smoking workforce.
These results highlight the importance of smoking prevention, the researchers said.
Monash University funded the study.
Salsabil Bilqis Maulida, Medical Student, Monash University, Melbourne, Australia Danny Liew, Ph.D., Monash University, Melbourne, Australia.
Presentation Location: Population Science Section, Science and Technology Hall
- Available B-roll, animation and images related to this news tip are on the right column of this link https://newsroom.heart.org/news/australian-workers-who-smoke-hit-national-pocketbook?preview=1cc8dbd26d64ca332cd183b206c701b8
- Quit Smoking
- For more news at AHA Scientific Sessions 2017, follow us on Twitter @HeartNews #AHA17.
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
About the American Heart Association
The American Heart Association is devoted to saving people from heart disease and stroke – the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.
For Media Inquiries and AHA Spokesperson Perspective:
AHA News Media in Dallas: 214-706-1173
AHA News Media Office, Nov. 11-15, 2017 at the Anaheim Convention Center: 714-765-2004
For Public Inquiries: 800-AHA-USA1 (242-8721)